Stock Market

Novavax’s Covid-19 vaccine still isn’t approved for use in the U.S. With the pandemic in full retreat and the majority of people now fully vaccinated, demand for Novavax’s vaccine is likely to be weak. Rival pharmaceutical companies Pfizer and Moderna have beat Novavax to market with multiple Covid-19 treatments. Source: rarrarorro / Shutterstock.com Any hope
0 Comments
The number of zombie companies ebbs and flows with economic cycles and usually increases during recessionary periods. Diebold Nixdorf (DBD): The ATM machines business contributes to top-line growth as customers increasingly shift toward automation and self-service. Mattel (MAT): The toy company plans to produce more than a dozen movies, including the highly anticipated Barbie movie in 2023.
0 Comments
EV upstart Lucid Motors (NASDAQ:LCID) delivered a strong earnings beat with its first-quarter results. Investors were lackadaisical, though, as LCID stock shed close to 12% of its value on its post-earnings sell-off. Analysts were expecting the EV firm to lose 31 cents per share on sales of $55.6 million. However, actual results came in significantly
0 Comments
ChargePoint (NYSE:CHPT) is a California-based company that provides electric vehicle (EV) charging networks and charging solutions. The company went public via a special-purpose acquisition company (SPAC) and was initially highly popular with traders. CHPT stock shot up as high as $45 in late 2020 following the launch of its SPAC deal. Since then, however, ChargePoint has
0 Comments